Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial

Research output: Contribution to journalJournal articleResearchpeer-review

  • Bernt Johan von Scholten
  • Frederik Persson
  • Signe Rosenlund
  • Jesper Eugen-Olsen
  • Tomasz Pielak
  • Faber, Jens
  • Tine W. Hansen
  • Rossing, Peter
Original languageEnglish
JournalDiabetes, Obesity and Metabolism
Volume19
Issue number6
Pages (from-to)901-905
ISSN1462-8902
DOIs
Publication statusPublished - 2017

    Research areas

  • clinical trial, GLP-1 analogue, liraglutide

ID: 188533203